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TO THE EDITOR
Membrane-associated phosphatidic acid–
preferring phospholipase A1a (PA-PLA1a,
also known as mPA-PLA1a and lipase H
(LIPH)) is an enzyme known to hydro-
lyze phosphatidic acid (PA) into 2-acyl
lysophosphatidic acid (LPA) and free
fatty acid (FFA; Sonoda et al., 2002;
Hiramatsu et al., 2003). It has recently
been shown that LPA, which is pro-
duced by PA-PLA1a, works as a ligand
for its receptor LPA6, also known as
P2Y5, and is speculated to regulate the
proliferation and differentiation of inner
root sheath cells of hair follicles (Inoue
et al., 2011). Recently, LIPH (MIM#
607365) and LPAR6 (MIM# 609239),
which encode PA-PLA1a and LPA6,
respectively, were identified as causative
genes for autosomal recessive woolly
hair with associated hypotrichosis (ARWH/
H; MIM# 604379, 278150; Kazantseva
et al., 2006; Pasternack et al., 2008;
Shimomura et al., 2008). To our knowl-
edge, we identified a previously unre-
ported heterozygous missense mutation
at the b9 loop domain of PA-PLA1a,
which is considered a crucial structure
for substrate recognition (Sonoda et al.,
2002; Aoki et al., 2007) in this study. To
clarify the role of the b9 loop domain,
the hydrolytic activity and LPA6 activa-
tion ability of mutant PA-PLA1a were
evaluated.
A 3-year-old Japanese girl was seen
at our hospital with woolly and sparse
hair on her scalp without other abnorm-
alities (Figure 1a). Her eyebrows and
eyelashes were slightly sparse. Her
parents were unrelated and nonconsan-
guineous, and had normal hair. Blood
samples were collected for DNA
extraction in accordance with standard
methods, and an LIPH mutation search
was performed as previously reported
(Shimomura et al., 2009). Direct se-
quencing analysis of all exons and
intron–exon boundaries of the LIPH
revealed that the patient was compound
heterozygous for the two missense
mutations c.619G4C (p.Asp207His)
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Figure 1. Clinical features and identification of mutations in the LIPH gene. (a) The affected individual has features of autosomal recessive woolly hair/
hypotrichosis, which is characterized by sparse woolly hair on the scalp and slightly sparse eyebrows and eyelashes. There are no other abnormalities. (b) Family
pedigree. The family history is consistent with autosomal recessive inheritance. Direct sequencing of the LIPH gene revealed that the patient had compound
heterozygous missense mutations involving c.619G4C and c.742C4A. The complementary DNA (cDNA) nucleotides and the amino acids of the protein were
numbered based on the previous sequence information (GenBank accession number; AY093498.1). Nucleotide numbering reflects cDNA numbering, with
þ1 corresponding to the A of the ATG translation initiation codon in the reference sequence, according to Human Genome Variation Society guidelines
(www.hgvs.org/mutnomen). The initiation codon is codon 1.
Abbreviations: a.a., amino acid; AP-TGFa, alkaline phosphatase–tagged transforming growth factor-a;
FFA, free fatty acid; LPA, lysophosphatidic acid; PA, phosphatidic acid; PA-PLA1a, membrane-associated
phosphatidic acid–preferring phospholipase A1a; PLA1, phospholipase A1; PS, phosphatidylserine;
PS-PLA1, phosphatidylserine-specific phospholipase A1; TG, triacylglycerol; WT, wild type
and c.742C4A (p.His248Asn), which
were segregated from her mother and
father, respectively (Figure 1b). These
mutations were verified by restriction
enzyme digestions of the PCR products
by Hpy188I and mutant allele–specific
amplification analysis, respectively
(Supplementary Figure S1 online). p.Hi-
s248Asn, one amino acid (a.a.) of the
catalytic triad, is known as a prevalent
pathogenic mutation in the Japanese
population (Shinkuma et al., 2010).
To the best of our knowledge,
c.619G4C (p.Asp207His) in LIPH is a
previously unreported mutation and
was not found in alleles from 100
normal unrelated individuals. Asp207
residue of PA-PLA1a is conserved among
diverse species, suggesting that Asp207
may have a critical role in enzyme activity
(Supplementary Figure 2a online). To
assess the role of Asp207 as a candidate
for the ARWH/H, two distinct in vitro
functional analyses were performed:
for hydrolytic activity and for LPA6
activation ability of PA-PLA1a (Shinkuma
et al., 2010).
To investigate the molecular defects
underlying the mutation, we synthe-
sized p.Asp207His PA-PLA1a expres-
sion constructs and compared the
mutant protein expression with wild-
type (WT) and with p.Ser154Ala, which
was known as a loss-of-function muta-
tion (Shinkuma et al., 2010; Sonoda
et al., 2002). Immunoblot analysis using
anti-PA-PLA1a monoclonal antibody
revealed that the transfection of p.As-
p207His constructs into HEK293 cells
resulted in the secretion of the
55-kDa mutant PA-PLA1a at levels
similar to those of WT and p.Ser154Ala
(Figure 2a; Sonoda et al., 2002). In
addition, the same amounts of mutant
PA-PLA1a proteins were also recovered
from the cell lysate (data not shown).
These results indicate that there was no
significant difference in protein amount
between WT and mutant PA-PLA1a.
Hydrolysis activity was determined
by measuring FFA, which was concur-
rently produced from PA by PA-PLA1a.
Briefly, we added the supernatant from
HEK293 cells transfected with WT,
p.Ser154Ala, or p.Asp207His PA-PLA1a
to a medium containing 400mM PA.
After 3 hours of incubation at 37 1C,
the amount of oleic acids, one kind
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Figure 2. Hydrolytic activity and LPA6 activation ability of p.Asp207His mutant membrane-associated
phosphatidic acid–preferring phospholipase A1a (PA-PLA1a). (a) Expression of p.Asp207His mutant PA-
PLA1a in HEK 293 cells. HEK 293 cells were transfected with wild-type (WT), p.Ser154Ala (S154A), and
p.Asp207His (D207H) LIPH cDNA, and the expression levels of PA-PLA1a protein derived from the
constructs in cell culture supernatant (upper panel) were compared. There were no significant differences
in PA-PLA1a protein expression levels among cells transfected with WT, S154A, and D207H. a-Tubulin
expression was used as a standard for assessing the total amount of proteins from cell lysate (lower panel).
(b) As PA-PLA1a hydrolyzes the free fatty acid (FFA) from phosphatidic acid (PA), we monitored the levels
of FFA to determine whether there were differences in PA-PLA1a hydrolytic activity between the WT and
each of the two mutants of PA-PLA1a. After 3 hours of incubation of the supernatant from HEK293 cells
expressing WT, S154A, or D207H PA-PLA1a, with a medium including 400 mM PA, the levels of FFA
hydrolyzed by D207H mutant PA-PLA1a were significantly lower than those hydrolyzed by WT PA-
PLA1a; however, the D207H PA-PLA1a slightly retained the function of hydrolytic activity compared with
control S154A mutant and the empty vector (mock). WT¼ Po0.001 and D207H¼ Po0.05 versus mock;
D207H¼ Po0.001 versus WT (one-way analysis of variance (ANOVA) with Dunnett’s post test).
(c) To monitor LPA6 activation level by mutant and WT PA-PLA1a, we used p-nitrophenyl phosphate
as a substrate for cleavage of alkaline phosphatase–tagged transforming growth factor-a (AP-TGFa)
and measured the amount of AP-TGFa released from the HEK293 cells. The amount of free AP-TGFa
produced by LPA6 mock-transfected (LPA6
) cells that were also transfected with WT PA-PLA1a was
significantly greater than that produced by LPA6
 cells transfected with an empty vector (mock PA-PLA1a).
This indicates that HEK293 cells act to shed AP-TGFa, an activity that might be mediated by intrinsic LPA
receptors. The amounts of AP-TGFa released from LPA6-transfected (LPA6
þ ) cells expressing S154A or
D207H mutant PA-PLA1a and LPA6
þ cells transfected with an empty vector (mock) are significantly lower
than those released from LPA6
þ cells expressing WT PA-PLA1a. WT¼ Po0.001, S154A¼not significant
(NS) and D207H¼NS versus mock (one-way ANOVA with Dunnett’s post test).
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of FFA, was measured using a NEFA
C-Test Wako test kit (Wako Chemicals,
Osaka, Japan; Shinkuma et al., 2010).
The quantities of oleic acids produced
by the p.Asp207His PA-PLA1a were
markedly lower than those for the WT;
however, the p.Asp207His PA-PLA1a
slightly retained the function of hydro-
lytic activity relative to mock and
p.Ser154Ala (Figure 2b).
To perform the LPA6 activation ability
assay, alkaline phosphatase–tagged
transforming growth factor-a (AP-TGFa;
kindly provided by Dr Higashiyama,
Ehime University, Japan; Tokumaru
et al., 2000), recombinant LPA6, and
PA-PLA1a constructs (WT, p.Ser154Ala
or p.Asp207His) were cotransfected to
HEK293 cells. To measure the LPA6
activation potency of mutant PA-PLA1a,
AP-TGFa release into conditioned med-
ia via a disintegrin and metalloprotease,
which was triggered by the activation of
LPA6, was quantified using p-NPP as a
substrate for AP (Shinkuma et al., 2010;
Inoue et al., 2011). As previously
reported, the free AP-TGFa from the
LPA6-untransfected (LPA6
) cells express-
ing the WT PA-PLA1a was more abun-
dant than that from the LPA6
 cells
transfected with mock PA-PLA1a,
which indicated that the HEK293 cells
had the ability to shed AP-TGFa mediated
by intrinsic LPA receptor at some level
(Figure 2c; Shinkuma et al., 2010; Inoue
et al., 2011). AP-TGFa release from
LPA6-transfected (LPA6
þ ) cells express-
ing the WT PA-PLA1a was remarkably
increased compared with mock or mutant
PA-PLA1a. There were no significant
differences between the data obtained
with cells expressing the mutant and
mock PA-PLA1a (Figure 2c). These data
indicate that the p.Asp207His PA-PLA1a
results in the complete loss of LPA6
activation activity. Despite the remain-
ing slight hydrolytic activity, there was
complete loss of LPA6 activation ability
and no significant difference in clinical
features between this patient and other
patients with LIPH mutations who were
revealed as having complete loss of
hydrolytic activity (Shinkuma et al.,
2010). These findings suggest that the
p.Asp207His PA-PLA1a retained slight
hydrolytic activity, which was insuffi-
cient to activate LPA6 and possibly
leading to woolly hair.
Phospholipase A1 (PLA1) is an enzyme
that hydrolyzes ester bonds of phos-
pholipids (Aoki, 2004). PLA1, such as
phosphatidylserine (PS)-specific PLA1
(PS-PLA1), PA-PLA1a, and PA-PLA1b,
form a subfamily in the pancreatic lipase
gene family (Sato et al., 1997; Sonoda
et al., 2002; Hiramatsu et al., 2003).
These PLA1 enzymes distinctly differ from
other lipases in that PLA1 enzymes do not
hydrolyze triacylglycerol (TG) and that
they show strict substrate specificities and
act specifically on PS and PA, respec-
tively (Sato et al., 1997; Sonoda et al.,
2002; Hiramatsu et al., 2003). The lipase
family has three a.a. residues that form
the putative catalytic triad and has three
surface loops called the lid, the b5 loop,
and the b9 loop that cover the active site
(Winkler et al., 1990; Carriere et al.,
1998; Aoki et al., 2007). A comparison of
the a.a. sequences of PLA1 and TG
lipases, such as pancreatic lipase and
lipoprotein lipase, revealed that PLA1
enzymes have shorter lid and b9 loop
than TG lipases (PLA1: 12 a.a. and 13
a.a.; TG lipases: 22–23 a.a. and 18–19
a.a., respectively; Supplementary Figure
2b online; Aoki et al., 2007). Therefore,
the lid, the b5 loop, and the b9 loop are
implicated in substrate specificity. In this
study, we identified the p.Asp207His
mutation at the b9-loop domain of PA-
PLA1a in the ARWH/H patient, and
clarified that the mutant showed sub-
stantial abolition of hydrolytic activity
and had no LPA6 activation ability. These
results confirm that the b9-loop domain
of PA-PLA1a has a crucial role in enzyme
activity.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank the patient and her parents for their
generous cooperation and Ms Junko Tamba and
Ms Yui Saito for their technical assistance. The
family gave written informed consent. The med-
ical ethics committee of Hokkaido University
approved all the described studies. The study
was conducted according to the Declaration of
Helsinki Principles. This work was supported by
the Naito Foundation.
Satoru Shinkuma1, Asuka Inoue2,
Junken Aoki2, Wataru Nishie1,
Ken Natsuga1, Hideyuki Ujiie1,
Toshifumi Nomura1, Riichiro Abe1,
Masashi Akiyama1,3 and
Hiroshi Shimizu1
1Department of Dermatology, Hokkaido
University Graduate School of Medicine,
Sapporo, Japan; 2Graduate School of
Pharmaceutical Sciences, Tohoku University,
Sendai, Japan and 3Department of
Dermatology, Nagoya University Graduate
School of Medicine, Nagoya, Japan
E-mail: qxfjc346@ybb.ne.jp
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online
version of the paper at http://www.nature.com/jid
REFERENCES
Aoki J (2004) Mechanisms of lysophosphatidic acid
production. Semin Cell Dev Biol 15:477–89
Aoki J, Inoue A, Makide K et al. (2007) Structure
and function of extracellular phospholipase
A1 belonging to the pancreatic lipase gene
family. Biochimie 89:197–204
Carriere F, Withers-Martinez C, van Tilbeurgh H et al.
(1998) Structural basis for the substrate selectiv-
ity of pancreatic lipases and some related
proteins. Biochim Biophys Acta 1376:417–32
Hiramatsu T, Sonoda H, Takanezawa Y et al.
(2003) Biochemical and molecular charac-
terization of two phosphatidic acid-selective
phospholipase A1s, mPA-PLA1alpha and
mPA-PLA1beta. J Biol Chem 278:49438–47
Inoue A, Arima N, Ishiguro J et al. (2011) LPA-
producing enzyme PA-PLA(1)a regulates hair
follicle development by modulating EGFR
signalling. EMBO J 30:4248–60
Kazantseva A, Goltsov A, Zinchenko R et al.
(2006) Human hair growth deficiency is
linked to a genetic defect in the phospholi-
pase gene LIPH. Science 314:982–5
Pasternack SM, von Kugelgen I, Aboud KA et al.
(2008) G protein-coupled receptor P2Y5
and its ligand LPA are involved in maintenance
of human hair growth. Nat Genet 40:329–34
Sato T, Aoki J, Nagai Y et al. (1997) Serine
phospholipid-specific phospholipase A that is
secreted from activated platelets. A new mem-
ber of the lipase family. J Biol Chem 272:2192–8
Shimomura Y, Wajid M, Ishii Y et al. (2008)
Disruption of P2RY5, an orphan G protein-
coupled receptor, underlies autosomal reces-
sive woolly hair. Nat Genet 40:335–9
Shimomura Y, Wajid M, Petukhova L et al. (2009)
Mutations in the lipase H gene underlie
autosomal recessive woolly hair/hypotricho-
sis. J Invest Dermatol 129:622–8
Shinkuma S, Akiyama M, Inoue A et al. (2010) Preva-
lent LIPH founder mutations lead to loss of P2Y5
activation ability of PA-PLA1alpha in autosomal
recessive hypotrichosis. Hum Mutat 31:602–10
Sonoda H, Aoki J, Hiramatsu T et al. (2002) A
novel phosphatidic acid-selective phospholi-
pase A1 that produces lysophosphatidic acid.
J Biol Chem 277:34254–63
Tokumaru S, Higashiyama S, Endo T et al. (2000)
Ectodomain shedding of epidermal growth
factor receptor ligands is required for kerati-
nocyte migration in cutaneous wound heal-
ing. J Cell Biol 151:209–20
Winkler FK, D’Arcy A, Hunziker W (1990) Structure
of human pancreatic lipase. Nature 343:771–4
www.jidonline.org 2095
S Shinkuma et al.
The Role of b9 Loop Domain in PA-PLA1a
